Galip Güz

ORCID: 0000-0002-9146-2133
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Renal Diseases and Glomerulopathies
  • Renal Transplantation Outcomes and Treatments
  • Iron Metabolism and Disorders
  • Pharmacological Effects and Toxicity Studies
  • Parathyroid Disorders and Treatments
  • Organ Donation and Transplantation
  • Hepatitis C virus research
  • Organ Transplantation Techniques and Outcomes
  • Systemic Lupus Erythematosus Research
  • Erythropoietin and Anemia Treatment
  • Cytomegalovirus and herpesvirus research
  • Chronic Kidney Disease and Diabetes
  • Acute Kidney Injury Research
  • Polyomavirus and related diseases
  • Renal and Vascular Pathologies
  • Pancreatitis Pathology and Treatment
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Inflammasome and immune disorders
  • Systemic Sclerosis and Related Diseases
  • Vasculitis and related conditions
  • Muscle and Compartmental Disorders
  • Acute Myocardial Infarction Research
  • Bone health and treatments
  • Potassium and Related Disorders

Gazi University
2014-2025

Yale University
2014

Fatih University
2011

Ghent University Hospital
2006

Pediatric Nephrology of Alabama
2005

Başkent University
1998-2004

Atherosclerosis is a disease of the arterial wall, with increasing wall thickness representing an early event in progression disease. It has been suggested that iron overload, as assessed by increased serum ferritin concentration, may be risk factor for atherosclerosis. The aim this study was to investigate relationship between influence intravenous (IV) therapy and levels carotid intima media (C-IMT) dialysis patients. Sixty patients (51 ± 14) years were divided into two groups according...

10.1536/ihj.46.255 article EN International Heart Journal 2005-01-01

Context: Ferric carboxymaltose (FCM) is a widely used therapy in chronic kidney disease (CKD). With its increasing use, hypophosphatemia -an unexpected side effect- has drawn growing attention. While the risk of decreases as stage progresses, impact ferric on parathormone levels and how this evolves with repeated doses remain less known. Objective: In our study, we planned to evaluate relationship phosphorus long term patients 2-5 non-dialysis disease. Method: All who received treatment...

10.22265/acnef.12.1.865 article EN Revista Colombiana de Nefrología 2025-04-21

Ocular surface changes and ocular symptoms may be encountered in patients with chronic renal failure (CRF) undergoing haemodialysis. The its relationship metabolic control CRF were aimed to emphasized this study.Thirty-eight (75 eyes) haemodialysis enrolled. Patients underwent a complete examination together Schirmer, tear break-up time tests, pachymetric measurements conjunctival impression cytologies. Blood calcium, phosphate levels total body volume after recorded.The most common findings...

10.1111/j.1440-1797.2007.00805.x article EN Nephrology 2007-05-25

Abstract We evaluated the symptoms, changes in laboratory findings during novel coronavirus disease (COVID‐19) pandemic, and effect of depression patients with peritoneal dialysis (PD). This is an observational cross‐sectional study. All were asked to fill clinical assessment form Beck anxiety inventory. Also, last two evaluations this period examined. A total 123 performing PD included. None diagnosed COVID‐19. In study population, parathyroid hormone (PTH), serum albumin, phosphorus...

10.1111/sdi.12940 article EN Seminars in Dialysis 2020-11-19

Background Management of acute kidney injury (AKI) in the ED can be difficult due to uncertainty regarding aetiology. This study investigated diagnostic value venous system ultrasound for determining aetiological subtypes AKI ED. Methods multidisciplinary prospective cohort was conducted a single academic over course year. Adult patients with were evaluated using excess (VExUS) score, which is four-step protocol. The protocol begins inferior vena cava (IVC) measurement and examines organ...

10.1136/emermed-2023-213241 article EN Emergency Medicine Journal 2024-02-14

<title>Abstract</title> Introduction: This study investigates hypersensitivity reactions (HSRs) associated with rituximab therapy in nephrology patients, focusing on identifying potential risk factors. Methods Records of patients treated our unit for kidney diseases were reviewed between January 2019 and June 2024. Demographic, clinical, laboratory data evaluated to identify factors HSRs. Patients premedicated paracetamol, diphenhydramine, corticosteroids before infusions. Binary logistic...

10.21203/rs.3.rs-5951214/v1 preprint EN Research Square (Research Square) 2025-04-28

Regulatory T cells (Tregs), which express CD4 and FOXP3, are critical for modulating the immune response promoting tolerance. Consequently, methods to expand Tregs therapeutic use of great interest. While transfer after massive ex vivo expansion can be achieved, in would more practical. Here, we demonstrate that targeting CD45 tyrosine phosphatase with a tolerogenic anti-CD45RB mAb acutely increases Treg numbers WT mice, even absence exogenous antigen. occurred through substantial...

10.1172/jci74087 article EN Journal of Clinical Investigation 2014-09-08

SUMMARY Ischaemia–reperfusion (I/R) injury, one of the main causes acute renal failure, still needs satisfactory treatment for routine clinical application. Stobadine, a novel synthetic pyridoindole anti‐oxidant, has ability to reduce tissue injury induced by mechanisms involving reactive oxygen species during I/R. The aim present study was determine effects stobadine on I/R injury. Forty male Wistar rats were randomly divided into four groups as follows: sham, I/R, treated and + treated....

10.1111/j.1440-1681.2007.04574.x article EN Clinical and Experimental Pharmacology and Physiology 2007-01-25

Familial Mediterranean Fever (FMF) is an autosomal recessive disease characterized by periodic attacks of fever and polyserositis. The effects the MEFV genotype differences on clinical picture inflammatory activity have not been well documented. aim this study was to investigate levels conventional inflammation markers, procalcitonin, interleukin levels, TNF-alpha, C5a in patients with FMF who had different genotypes compare them those healthy subjects. consisted 41 (F/M: 23/18), 31 subjects...

10.1080/08860220701810364 article EN Renal Failure 2008-01-01

Background: Diabetic nephropathy (DN) is a leading cause of diabetes-related morbidity and mortality. The aim this study was to evaluate the relationship AGT M235T apoprotein E (APO E) gene polymorphism with DN in Turkish patients Type 2 diabetes, compare genotype allele distributions among patients, non-DN healthy controls. Methods: APO analysis were performed 111 108 106 control subjects for genotype, 100 polymorphism. determined by RFLP-PCR. Results: frequencies ε2/3, ε 3/3, 3/4 genotypes...

10.3109/0886022x.2011.568133 article EN other-oa Renal Failure 2011-04-18

Background and Objectives Aberrant circadian rhythm with persistent nocturnal sympathetic hyperactivity has pointed out malfunctioning autonomic nervous system in fibromyalgia (FM) patients. This is a common pathogenesis shared also by patients nondipping blood pressure (BP) pattern. Therefore, we aimed to investigate the frequency of BP pattern normotensive women newly diagnosed FM compared healthy women. Methods Sixty-seven new diagnosis 38 age-matched volunteer were recruited into study....

10.1097/rhu.0000000000000189 article EN JCR Journal of Clinical Rheumatology 2014-12-01

Objective TO report a case of nephrotic syndrome (NS) induced by both sunitinib and sorafenib therapy. Case Summary A 61-year-old woman with metastatic gastrointestinal stromal tumor (GIST) presented NS hypertension following therapy 400 mg/day. Because grade 3 toxicity, the drug was discontinued. After discontinuation, resolved. However, recurred on rechallenge. similar picture developed 800 renal biopsy revealed focal segmental glomerulosclerosis (FSGS). few months after cessation,...

10.1345/aph.1r160 article EN Annals of Pharmacotherapy 2012-10-01
Coming Soon ...